Breast Cancer, Pfizer

ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements.
Trusting My Stage 4 Breast Cancer Body
After my last fall, where I broke both my upper front teeth and had abrasions on my face, I had to go to the ER to be checked for those and have my brain scanned in case of cancer progression. I had to start walking very slowly and watching every little step.
Pfizer-Arvinas' breast cancer treatment shows mixed results in late-stage study
Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of patients in a late-stage trial, sending the Connecticut-based biotech's shares down 36% before the bell.
Pfizer and Arvinas’s HER2-breast cancer drug extends PFS in certain patients
Pharma giant Pfizer and Arvinas’s human epidermal growth factor receptor 2 (HER2) negative breast cancer therapy, vepdegestrant, has seen mixed results after it was only able to extend progression-free survival (PFS) in certain patients in a Phase III trial.
Pfizer, Arvinas post mixed late-stage trial results for breast cancer therapy (update)
Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental breast cancer drug vepdegestrant announced mixed initial results from a Phase 3 trial for the protein degrader on Tuesday.
Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug
Arvinas stock lost half its value Tuesday after the biotech company reported mixed results from its Pfizer-partnered breast cancer drug.
Understanding Metastatic Breast Cancer: An In-Depth Look
Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...
‘Breastie Friends Forever:’ Pals since childhood, Staten Island breast cancer survivors strut runway to raise $500K
"Making lemonade out of our breast cancer journeys. Join our community to feel support and strength as we share it all." ...
Psychology Today1d
Shifting the Conversation Regarding Breast Cancer
Public-facing conversation regarding breast cancer is grounded in historical gender bias and is an example of the disparities ...
BlackDoctor.org1h
Why Triple-Negative Breast Cancer Patients Need Clinical Trials
Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.
Us Weekly1h
A Timeline of Former Bachelorette Katie Thurston’s Breast Cancer Battle: From Diagnosis to Treatment
Katie Thurston was diagnosed with breast cancer in February 2025 at the age of 34.
Irish Examiner on MSN8h
I was shocked to be diagnosed with triple-negative breast cancer in my 40s
Ciara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative ...
Fitgurú on MSN23h
What you should do every day to reduce breast cancer risk, experts say
Regular physical activity is one of the most effective strategies to combat this disease, offering benefits that go beyond ...
Breast cancer: 'My 3D nipple tattoo completes me'
A father-of-three who had cancerous breast tissue removed said he feels "complete" again after getting a realistic "3D" ...
NWAhomepage45m
Eliminating barriers to diagnostic breast cancer care: Arkansas House Bill 1309 signed into law
A new law in Arkansas aims to remove the barriers associated with receiving breast cancer examinations. The bill was introduced by Representative Ryan Rose, a ...
Bill Aims To Expand Breast Cancer Screening To Over 800,000 Americans
Advocates argue that out-of-pocket costs for additional imaging, such as MRIs or diagnostic mammograms, deter patients from seeking necessary follow-up exams.
St. Louis Magazine20h
WashU research reveals rise in breast cancer in women under 50
But the MRI uncovered a tumor, and subsequent mammograms and biopsies confirmed she had breast cancer. Researchers at ...